Milestone Pharmaceuticals Inc.

CIK 1408443 · 425 filings in 37 form types · 2007-07-30 to 2026-11-20 · MIST

FiledFormCategory8-K items / descriptionAccession
2026-11-20 SCHEDULE 13G/A Ownership 0001969764-26-000002
2026-11-19 3 Ownership 0001932659-26-000004
2026-11-13 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001104659-26-126519
2026-11-13 10-Q Financial reports 10-Q 0001104659-26-126504
2026-10-28 8-K Current reports 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 0001104659-26-119669
2026-09-03 8-K Current reports 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001104659-26-105052
2026-08-12 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001104659-26-094466
2026-08-12 10-Q Financial reports 10-Q 0001104659-26-094435
2026-08-07 SCHEDULE 13G Ownership 0002143027-26-000012
2026-06-15 8-K Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits 0001104659-26-074025
2026-06-12 4 Ownership 0001970274-26-000004
2026-06-12 4 Ownership 0001634189-26-000002
2026-06-12 4 Ownership 0001616284-26-000002
2026-06-12 4 Ownership 0001573553-26-000002
2026-06-12 4 Ownership 0001570392-26-000003
2026-06-12 4 Ownership 0001568850-26-000002
2026-06-12 4 Ownership 0001242215-26-000014
2026-05-22 EFFECT Registrations and prospectuses 9999999995-26-001747
2026-05-20 CORRESP Other 0001104659-26-064183
2026-05-18 UPLOAD Other 0000000000-26-005086
2026-05-15 SCHEDULE 13G/A Ownership 0001493215-26-000112
2026-05-13 S-3 Registrations and prospectuses 0001104659-26-060391
2026-05-13 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001104659-26-059780
2026-05-13 10-Q Financial reports 10-Q 0001104659-26-059752
2026-05-13 SCHEDULE 13G/A Ownership 0000919574-26-002920
2026-04-30 ARS Financial reports 0001104659-26-052913
2026-04-30 DEFA14A Proxies 0001104659-26-052893
2026-04-30 DEF 14A Proxies 0001104659-26-052880
2026-04-20 4 Ownership 0001437782-26-000010
2026-04-16 144 Ownership 0001950047-26-003561
2026-03-26 SCHEDULE 13G/A Ownership 0001493152-26-013007
2026-03-23 3 Ownership 0002012430-26-000002
2026-03-20 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001104659-26-032427
2026-03-20 10-K Financial reports 10-K 0001104659-26-032415
2026-02-05 4/A Ownership 0001943112-26-000005
2026-02-05 4/A Ownership 0001910985-26-000006
2026-02-05 4/A Ownership 0001787700-26-000005
2026-02-05 4/A Ownership 0001771207-26-000005
2026-02-05 4/A Ownership 0001437782-26-000007
2026-02-04 4 Ownership 0001943112-26-000004
2026-02-04 4 Ownership 0001910985-26-000005
2026-02-04 4 Ownership 0001787700-26-000004
2026-02-04 4 Ownership 0001771207-26-000004
2026-02-04 4 Ownership 0001437782-26-000006
2026-01-28 4 Ownership 0001943112-26-000002
2026-01-28 4 Ownership 0001910985-26-000003
2026-01-28 4 Ownership 0001787700-26-000002
2026-01-28 4 Ownership 0001771207-26-000002
2026-01-28 4 Ownership 0001437782-26-000004
2026-01-26 8-K Current reports 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001104659-26-006483